醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
CRSP · CRISPR Therapeutics AG
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
CRISPR Therapeutics AG（CRSP）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $4.9M；高管董事有效買入 —、有效賣出 —。最近申報 2026-10-20。
買入 Bought—
賣出 Sold$4.9M
有效買入 Effective bought—
有效賣出 Effective sold—
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-10-19 | Kulkarni Samarth Chief Executive Officer, Director | 賣出 Sell | 47,837 | $49.78 | $2.4M | SEC |
| 2026-10-14 | George Simeon Director | 賣出 Sell | 14,514 | $49.63 | $720K | SEC |
| 2026-10-14 | Kulkarni Samarth Chief Executive Officer, Director | 賣出 Sell | 4,098 | $49.26 | $202K | SEC |
| 2026-10-14 | KASINGER JAMES R. General Counsel and Secretary | 賣出 Sell | 1,040 | $49.26 | $51K | SEC |
| 2026-10-06 | KASINGER JAMES R. General Counsel and Secretary | 賣出 Sell | 1,990 | $60.04 | $119K | SEC |
| 2026-09-22 | KASINGER JAMES R. General Counsel and Secretary | 賣出 Sell | 10,400 | $60.24 | $626K | SEC |
| 2026-09-17 | Behbahani Ali Director | 賣出 Sell | 13,679 | $57.09 | $781K | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-10-14 | George Simeon Director | 14,514 | $720K | |
| 2026-10-06 | KASINGER JAMES R. Officer | 1,990 | $119K | 10b5-1 |
| 2026-09-22 | KASINGER JAMES R. Officer | 10,400 | $626K | 10b5-1 |
| 2026-09-17 | Behbahani Ali Director | 13,679 | $781K |
內部人 Insiders
Kulkarni Samarth、George Simeon、KASINGER JAMES R.、Behbahani Ali